Science Explorer Interactive view Map
Company · Neu-Ulm · Germany

Nuvisan (Germany)

nuvisan.de/startseiteROR OpenAlex
Research works
61
▲ 299% vs 2013–17
Citations
931
15.4 per fractional work
Top-10% rate
16.1%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Nuvisan (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.38× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.90× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 10.72× its world share, 3 worksImmunology and Micro…Neuroscience: 0.85× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.39× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.28× its world share, 1 worksChemistryComputer Science: 0.43× its world share, 1 worksComputer ScienceEngineering: 0.15× its world share, 1 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.49× its world share, 0 worksMaterials ScienceMathematics: 0.56× its world share, 0 worksMathematicsPhysics and Astronomy: 0.52× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 1.41× its world share, 8 worksMedicineVeterinary: 9.36× its world share, 0 worksVeterinaryDecision Sciences: 0.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.14× its world share, 0 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.7×. Every wedge is a field page.

Which keywords describe research at Nuvisan (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Immunotherapy, Monoclonal Antibodies, Tumor Regression, Tumor Microenvironment and Tumor Targeting.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer5▲ 12×18 topics
  2. Inflammation3▲ 5.1×17 topics
  3. Cancer Therapy3▲ 17×12 topics
  4. Immunotherapy2▲ 9.5×3 topics
  5. Monoclonal Antibodies2▲ 62×3 topics
  6. Tumor Regression2▲ 50×2 topics
  7. Tumor Microenvironment1▲ 9.8×5 topics
  8. Angiogenesis1▲ 12×6 topics
  9. Lymphoma1▲ 26×2 topics
  10. Metabolism1▲ 8.1×4 topics
  11. Tumor Targeting1▲ 24×2 topics
  12. Arginine Deprivation1▲ 103×1 topic
  13. Bacterial Therapy1▲ 103×1 topic
  14. Drug Discovery1▲ 17×5 topics
  15. Gene Therapy1▲ 20×2 topics
  16. Glycosylation1▲ 34×3 topics
  17. Pharmacokinetics1▲ 13×2 topics

Which research topics does Nuvisan (Germany) publish most on?

By volume in 2022–2025: Cancer Research and Treatments, Biosimilars and Bioanalytical Methods, Immune cells in cancer and Lymphoma Diagnosis and Treatment.

Cancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksImmune cells in cancer: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksProtein Structure and Dynamics: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksHippo pathway signaling …1Hippo pathway signaling and YAP/TAZ: 1 fractional worksCAR-T cell therapy research: 0 fractional worksRNA modifications and cancer: 0 fractional works
BiotechnologyImmunologyPathology and Forensic MedicineRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Research and Treatments Biotechnology 1 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 1 works
  3. 3 Immune cells in cancer Immunology 1 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Protein Structure and Dynamics Molecular Biology 1 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  8. 8 Hippo pathway signaling and YAP/TAZ Cell Biology 1 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 RNA modifications and cancer Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 28% of research is openly available.

with international co-authors60.0%domestic only40.0%

World: 19% is written across borders.

How has Nuvisan (Germany)'s research output changed?

Output in 2018–2022 was 299% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Neu-Ulm

All research institutions in Neu-Ulm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.